I Hate Dialysis Message Board
Dialysis Discussion => Dialysis: News Articles => Topic started by: greg10 on May 19, 2011, 04:23:02 PM
-
Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal Dialysis
A few of our members have mentioned the benefits of the over the counter supplement Benfotiamine (http://en.wikipedia.org/wiki/Benfotiamine). It turns out that it is protective of damages caused by glucose and may have implication for diabetics as well.
http://jasn.asnjournals.org/content/22/5/914.abstract
Residual renal function and the integrity of the peritoneal membrane contribute to morbidity and mortality among patients treated with peritoneal dialysis. Glucose and its degradation products likely contribute to the deterioration of the remnant kidney and damage to the peritoneum. Benfotiamine decreases glucose-induced tissue damage, suggesting the potential for benefit in peritoneal dialysis. Here, in a model of peritoneal dialysis in uremic rats, treatment with benfotiamine decreased peritoneal fibrosis, markers of inflammation, and neovascularization, resulting in improved characteristics of peritoneal transport. Furthermore, rats treated with benfotiamine exhibited lower expression of advanced glycation endproducts and their receptor in the peritoneum and the kidney, reduced glomerular and tubulointerstitial damage, and less albuminuria. Increased activity of transketolase in tissue and blood contributed to the protective effects of benfotiamine. In primary human peritoneal mesothelial cells, the addition of benfotiamine led to enhanced transketolase activity and decreased expression of advanced glycation endproducts and their receptor. Taken together, these data suggest that benfotiamine protects the peritoneal membrane and remnant kidney in a rat model of peritoneal dialysis and uremia.